Table 2 Distribution of patients with and without inhibitor, high and low responders, transient, slowly resolving and permanent dependent on the mutation type
N° of patients | NULL mutations inversions (Int1/22) | NULL mutations other | NOT null mutations | Unknown mutation | Total |
|---|---|---|---|---|---|
N = 156 | N = 79 | N = 91 | N = 198 | N = 524 | |
Without inhibitor | 87 | 40 | 68 | 149 | 344 |
With inhibitor | 69 | 39 | 23 | 49 | 180 |
Transient | 17 (25%) | 14 (36%) | 10 (44%) | 29 (59%) | 70 (39%) |
Slowly resolving | 20 (29%) | 6 (15%) | 7 (30%) | 14 (29%) | 47 (26%) |
Permanent | 32 (46%) | 19 (49%) | 6 (26%) | 6 (12%) | 63 (35%) |
High Responders | 38 (55%) | 21 (54%) | 7 (30%) | 13 (27%) | 79 (44%) |
Low Responders | 31 (45%) | 18 (46%) | 16 (70%) | 36 (73%) | 101 (56%) |